Medartis Holding AG
SIX:MED

Watchlist Manager
Medartis Holding AG Logo
Medartis Holding AG
SIX:MED
Watchlist
Price: 51.7 CHF 0.98% Market Closed
Market Cap: 702.9m CHF
Have any thoughts about
Medartis Holding AG?
Write Note

Medartis Holding AG
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medartis Holding AG
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Medartis Holding AG
SIX:MED
Accrued Liabilities
CHf6.5m
CAGR 3-Years
40%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Alcon AG
SIX:ALC
Accrued Liabilities
$1.2B
CAGR 3-Years
14%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Coltene Holding AG
SIX:CLTN
Accrued Liabilities
CHf15.1m
CAGR 3-Years
-1%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Ypsomed Holding AG
SIX:YPSN
Accrued Liabilities
CHf59.7m
CAGR 3-Years
22%
CAGR 5-Years
17%
CAGR 10-Years
11%
IVF Hartmann Holding AG
SIX:VBSN
Accrued Liabilities
CHf9.7m
CAGR 3-Years
5%
CAGR 5-Years
9%
CAGR 10-Years
2%
No Stocks Found

Medartis Holding AG
Glance View

Market Cap
702.1m CHF
Industry
Health Care

Medartis Holding AG operates as a medical device company. The company is headquartered in Basel, Basel-Stadt and currently employs 684 full-time employees. The company went IPO on 2018-03-23. The Group develops, manufactures and distributes to surgeons, hospitals and medical centers titanium screws, plates, surgical instruments and system solutions for internal fracture fixation. Medartis AG, the Company's wholly-owned subsidiary, has developed such technologies as TriLock for locking the screw into the plate, SpeedTip, a screw that does not require pre-drilling, and HexaDrive self-holding screw and screw-driver. The company has two product lines. The APTUS product line comprises upper and lower extremities products for hand, wrist, elbow, shoulder and foot fixation. The MODUS line combines products dedicated to cranio-maxillofacial (CMF) surgery. The Group's products are sold globally in more than 30 countries, including Germany and the United States, either directly through its sales subsidiaries, or through third-party distributors.

MED Intrinsic Value
80.96 CHF
Undervaluation 36%
Intrinsic Value
Price

See Also

What is Medartis Holding AG's Accrued Liabilities?
Accrued Liabilities
6.5m CHF

Based on the financial report for Jun 30, 2024, Medartis Holding AG's Accrued Liabilities amounts to 6.5m CHF.

What is Medartis Holding AG's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
32%

Over the last year, the Accrued Liabilities growth was 195%. The average annual Accrued Liabilities growth rates for Medartis Holding AG have been 40% over the past three years , 32% over the past five years .

Back to Top